Bone Marrow Transplantation News

Healio | HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in oncology and hematology.

SAN DIEGO — Before undergoing hematopoietic stem cell transplant, over 10% of patients had a penicillin allergy label but less than 1% had been tested for this allergy, according to a presentation here.

Fluoroquinolone exposure did not appear to increase the risk for developing vancomycin-resistant Enterococcus colonization following pediatric hematopoietic cell transplantation, a study found.

The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following haploidentical hematopoietic stem cell transplantation, according to results of a single-arm study.

Aplastic anemia is a bone marrow failure process that presents with pancytopenia and bone marrow hypoplasia/aplasia.

Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression of signals from nerves that promote bone marrow regeneration, according to study results.

More than one-quarter of blood or marrow transplant survivors developed cutaneous malignant neoplasms, according to study results.

Pre-transplant immune checkpoint inhibitors extended survival for patients with relapsed classic Hodgkin lymphoma compared with chemotherapy, according to results of a retrospective study.

Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.